evaluation of Curcuma tablet efficacy in nonalcoholic fatty liver patients
Not Applicable
Recruiting
- Conditions
- nonalcoholic fatty liver.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT20170722035222N2
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
patients who diagnosed as NAFLT with examination, liver function tests, sonography, history taking and high AST ALT
age 30-65 year
sign up the testimonial
Exclusion Criteria
smoking or drug abuse
diabetes
alcoholic
viral hepatitis
infection disease
cirrhosis
history of using hepatotoxic drugs such as methotrexate, amiodarone, valproic acid, anabolic steroid, estrogen, glucocorticoids and ...
being pregnant or lactating
hypotension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AST. Timepoint: Before intervention and 8 weeks after drug therapy. Method of measurement: Serum per liter in biochemical tests.;ALT. Timepoint: Before intervention and 8 weeks after drug therapy. Method of measurement: Serum per liter in biochemical tests.;Liver sonography. Timepoint: Before intervention and 8 weeks after drug therapy. Method of measurement: Assessing the grade of fatty liver based on the accumulation of fatty vacuoles in liver cells.
- Secondary Outcome Measures
Name Time Method BMI. Timepoint: Before intervention and 8 weeks after drug therapy. Method of measurement: In kilograms per meter using the BMA calculation formula.;FBS. Timepoint: Before intervention and 8 weeks after drug therapy. Method of measurement: In mg per deciliter in biochemical tests.;Weight. Timepoint: Before intervention and 8 weeks after drug therapy. Method of measurement: In kilograms using digital scales.